While the initial tumor did not stain for BCL2 by immunohistochemistry, the recurrent tumor tissue taken to establish the cell line stained positive for BCL2 in 50 % of tumor cells (Supplementary Figure 1). This evidence concerns the gene BCL2 and neoplasm.